Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3694053015 | Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3694054014 | Chlorhexidine hydrochloride 2.5 mg/g and tolnaftate 10 mg/g cutaneous powder | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
4655491000052117 | klorhexidinhydroklorid 2,5 milligram/gram och tolnaftat 10 milligram/gram, puder | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Is a | Product containing tolnaftate (medicinal product) | false | Inferred relationship | Some | ||
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has active ingredient | Local anti-infective | false | Inferred relationship | Some | ||
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has active ingredient | Tolnaftate (substance) | false | Inferred relationship | Some | ||
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has active ingredient | hudläkemedel och kosmetisk produkt | false | Inferred relationship | Some | ||
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has active ingredient | Chlorhexidine hydrochloride | false | Inferred relationship | Some | ||
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Is a | Tolnaftate+chlorhexidine hydrochloride | false | Inferred relationship | Some | ||
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has active ingredient | Local anti-infective | false | Inferred relationship | Some | ||
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has active ingredient | lokal produkt eller lokalt medel | false | Inferred relationship | Some | ||
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Is a | Product containing chlorhexidine and tolnaftate (medicinal product) | false | Inferred relationship | Some | ||
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has active ingredient | hudläkemedel och kosmetisk produkt | false | Inferred relationship | Some | ||
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has manufactured dose form | kutan och/eller transdermal läkemedelsform | false | Inferred relationship | Some | ||
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has manufactured dose form | läkemedelspulver | false | Inferred relationship | Some | ||
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has manufactured dose form | Cutaneous powder | true | Inferred relationship | Some | ||
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Is a | klorhexidin för lokalt bruk | false | Inferred relationship | Some | ||
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Is a | tolnaftat för lokalt bruk | false | Inferred relationship | Some | ||
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | har täljarvärde för koncentrationsstyrka | 2.5 (qualifier value) | false | Inferred relationship | Some | 1 | |
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has basis of strength substance (attribute) | Tolnaftate (substance) | false | Inferred relationship | Some | 2 | |
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | har nämnarvärde som visar koncentrationsstyrka | 1 (qualifier value) | false | Inferred relationship | Some | 1 | |
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | räkning av bas i aktiv ingrediens | 2 (qualifier value) | false | Inferred relationship | Some | ||
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | har nämnarvärde som visar koncentrationsstyrka | 1 (qualifier value) | false | Inferred relationship | Some | 2 | |
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has concentration strength denominator unit | g | true | Inferred relationship | Some | 1 | |
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has precise active ingredient | Tolnaftate (substance) | false | Inferred relationship | Some | 2 | |
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has precise active ingredient | Chlorhexidine hydrochloride | false | Inferred relationship | Some | 1 | |
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has basis of strength substance (attribute) | Chlorhexidine hydrochloride | false | Inferred relationship | Some | 1 | |
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has concentration strength denominator unit | g | true | Inferred relationship | Some | 2 | |
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | har täljarvärde för koncentrationsstyrka | 10 (qualifier value) | false | Inferred relationship | Some | 2 | |
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Is a | Product containing only chlorhexidine and tolnaftate in cutaneous dose form (medicinal product form) | true | Inferred relationship | Some | ||
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Plays role | Antifungal therapeutic role (role) | true | Inferred relationship | Some | ||
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has basis of strength substance (attribute) | Tolnaftate (substance) | true | Inferred relationship | Some | 1 | |
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has precise active ingredient | Tolnaftate (substance) | true | Inferred relationship | Some | 1 | |
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has basis of strength substance (attribute) | Chlorhexidine hydrochloride | true | Inferred relationship | Some | 2 | |
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has precise active ingredient | Chlorhexidine hydrochloride | true | Inferred relationship | Some | 2 | |
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Is a | Product containing biguanide (product) | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets